Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Remus Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
78788
INE0O5T01011
139.278683
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
REMUS
82.72
1390.04
EPS(TTM)
Face Value(
)
Div & Yield %:
28.52
10
0
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Sales Turnover
63.50
45.03
24.72
18.42
11.92
Excise Duty
0.00
0.00
0.00
0.00
0.00
Net Sales
63.50
45.03
24.72
18.42
11.92
Other Income
3.69
1.58
0.72
0.81
0.85
Stock Adjustments
1.38
-1.30
0.44
0.71
0.40
Total Income
68.57
45.31
25.88
19.94
13.17
EXPENDITURE :
Raw Materials
29.21
20.14
12.71
12.21
7.44
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.01
Employee Cost
6.56
5.47
3.42
2.95
2.86
Other Manufacturing Expenses
5.33
4.57
2.02
0.00
0.26
Selling & Administrative Expenses
3.55
2.98
2.70
0.00
1.37
Miscellaneous Expenses
0.18
0.02
0.17
3.17
0.00
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
Total Expenditure
44.83
33.18
21.02
18.33
11.93
Operating Profit
23.74
12.12
4.86
1.61
1.24
Interest
0.32
0.23
0.09
0.03
0.04
Gross Profit
23.42
11.89
4.77
1.58
1.20
Depreciation
0.90
0.48
0.15
0.18
0.11
Profit Before Tax
22.52
11.41
4.62
1.40
1.09
Tax
6.42
3.00
1.19
0.37
0.31
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
Deferred Tax
-0.71
-0.09
-0.01
-0.02
-0.02
Reported Net Profit
16.82
8.50
3.43
1.06
0.81
Extraordinary Items
0.01
0.00
0.01
0.08
0.00
Adjusted Net Profit
16.81
8.50
3.42
0.98
0.81
Adjustment below Net Profit
0.00
-0.20
-0.99
0.00
0.00
P & L Balance brought forward
13.89
5.58
3.13
2.07
1.20
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
Appropriations
0.59
0.00
0.00
0.00
0.00
P & L Balance carried down
30.12
13.89
5.58
3.13
2.01
Dividend
0.59
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
0.00
20.00
0.00
0.00
0.00
Dividend Per Share(Rs)
0.00
2.00
0.00
0.00
0.00
Earnings Per Share-Unit Curr
114.19
78.37
34.34
1059.50
811.60
Earnings Per Share(Adj)-Unit Curr
28.55
78.37
34.34
1059.50
811.60
Book Value-Unit Curr
557.11
176.36
65.78
3143.70
2020.30
Book Value(Adj)-Unit Curr
139.28
176.36
65.78
3143.70
2020.30